Purchase Description Ado-trastuzumab emtansine is a HER2-targeted antibody-drug conjugate which contains the humanized anti-HER2 IgG1, trastuzumab, covalently linked to the microtubule inhibitory drug DM1 via the stable thioether linker MCC. Trastuzumab is produced by Chinese hamster ovary cells, and DM1-MCC are produced by chemical synthesis. Ado-trastuzumab emtansine contains an average of 3.5 DM1 molecules per antibody. Ado-trastuzumab emtansine is supplied at a concentration of 20 mg/mL as a sterile, clear and colorless, preservative-free solution, which contains polysorbate 20 [0.02% (w/v)], sodium succinate (10 mM), and sucrose [6% (w/v)] with a pH of 5.0. Properties
-70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light.
Supply Ability 20 kilogram per year, Minimum order quantity is 1 gram. Price Inquiry Material Safety Data Sheet If you need more information, please contact us. Certificate Of Analysis Detail information about the product please refer the website below: https://en.wikipedia.org/wiki/Trastuzumab_emtansine